Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hehlmann

Showing results (81-90 of 310) with videos related to

Pageof 31
Sort By:
Der Internist|April 20, 2002
[Current pharmacotherapy of chronic myeloid leukemia]A Hochhaus, U Berger, A Reiter, et al.
Seminars in Hematology|July 1, 1993
Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Annals of Hematology|August 31, 2000
Current trends in the management of chronic myelogenous leukemiaR Hehlmann, A Hochhaus, U Berger, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 26, 2002
[Echocardiographic detection of tricuspid valve endocarditis and right atrial and ventricular masses in a patient with acute myeloid leukaemia]D Buchheidt, A Weiss, H Jakob, et al.
Klinische Wochenschrift|March 1, 1989
Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitizationG Papakonstantinou, H Füessl, A Matuschke, et al.
Fortschritte Der Medizin|March 12, 1981
[Joint diseases as the early clinical symptom of hemochromatosis]B Walther, B Zönnchen, R Hehlmann, et al.
Journal of Immunological Methods|November 6, 1990
Quantitative determination of retrovirus-specific immune complexesH Schetters, H Rohmer, R Hehlmann, et al.
Bone Marrow Transplantation|March 29, 2011
Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitorsS Saussele, R Hehlmann, A Gratwohl, et al.
Klinische Wochenschrift|March 1, 1988
[Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses]M Jahn, B Zönnchen, W Köpcke, et al.
Deutsche Medizinische Wochenschrift (1946)|February 9, 2007
[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia]E Lengfelder, B Schultheis, T Büchner, et al.
Pageof 31

Showing results (81-90 of 310) with videos related to

Sort By:
Pageof 31
Der Internist|April 20, 2002
[Current pharmacotherapy of chronic myeloid leukemia]A Hochhaus, U Berger, A Reiter, et al.
Seminars in Hematology|July 1, 1993
Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Annals of Hematology|August 31, 2000
Current trends in the management of chronic myelogenous leukemiaR Hehlmann, A Hochhaus, U Berger, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 26, 2002
[Echocardiographic detection of tricuspid valve endocarditis and right atrial and ventricular masses in a patient with acute myeloid leukaemia]D Buchheidt, A Weiss, H Jakob, et al.
Klinische Wochenschrift|March 1, 1989
Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitizationG Papakonstantinou, H Füessl, A Matuschke, et al.
Fortschritte Der Medizin|March 12, 1981
[Joint diseases as the early clinical symptom of hemochromatosis]B Walther, B Zönnchen, R Hehlmann, et al.
Journal of Immunological Methods|November 6, 1990
Quantitative determination of retrovirus-specific immune complexesH Schetters, H Rohmer, R Hehlmann, et al.
Bone Marrow Transplantation|March 29, 2011
Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitorsS Saussele, R Hehlmann, A Gratwohl, et al.
Klinische Wochenschrift|March 1, 1988
[Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses]M Jahn, B Zönnchen, W Köpcke, et al.
Deutsche Medizinische Wochenschrift (1946)|February 9, 2007
[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia]E Lengfelder, B Schultheis, T Büchner, et al.
Pageof 31